Unichem Labs gets USFDA nod to market anxiety disorder tablets

Unichem Labs gets USFDA nod to market anxiety disorder tablets The company has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) to market its Buspirone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, and 30 mg, Unichem Laboratories said in a BSE filing.

No comments:

Post a Comment